Gladstone in the News
November 13, 2020
The Wall Street Journal—Chief Information Officer Scott Pegg explains how his IT team adapted quickly to the COVID-19 pandemic to provide Gladstone researchers with the computing and storage power they needed to work on large data sets—in particular image data—from their homes.
Information Technology
Gladstone Experts
Gladstone in the News
November 5, 2020
Nature—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, explains how the CRISPR-based coronavirus test she recently developed with Nobel Laureate and Senior Investigator Jennifer Doudna, PhD, measures up against conventional, PCR-based tests.
Gladstone Experts
COVID-19
Virology
Doudna Lab
Ott Lab
CRISPR/Gene Editing
Gladstone in the News
November 1, 2020
USA Today—California Proposition 14 put funding for the Stem Cell Research Institute on the ballot this year. Gladstone President Deepak Srivastava, MD, explains how previous funding for stem cell research in California has helped bring the field to a point where stem cell–based therapies are now possible.
Gladstone Experts
Cardiovascular Disease
Srivastava Lab
Stem Cells/iPSCs
Gladstone in the News
October 30, 2020
TED—In a March talk selected this week for the TED homepage, Senior Investigator Leor Weinberger, PhD, describes an intriguing type of vaccine his lab is developing and that, like the viruses it aims to neutralize, can mutate and spread from person to person.
Gladstone Experts
HIV/AIDS
Center for Cell Circuitry
Virology
Weinberger Lab
Video
October 28, 2020
Tyrone Porter offers his best prescription for confronting what can often be a silent burden and putting a stop to the cultural tax many pay.
Communications
Diversity
Gladstone in the News
October 28, 2020
USA Today—Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, shares her view of CRISPR-based coronavirus detection kits and the possibility they might be deployed during the current pandemic. She and Senior Investigator Melanie Ott, MD, PhD, recently described the test they developed together in a publication posted on the electronic preprint platform bioRxiv.
Gladstone Experts
COVID-19
Data Science and Biotechnology
Virology
Doudna Lab
Ott Lab
CRISPR/Gene Editing
Article
October 26, 2020
Celebrate Halloween from the comfort of your own home. Gladstone’s Art Department has designed these ghastly coloring sheets for the young or young at heart.
Gladstone in the News
October 18, 2020
San Francisco Chronicle—Some of the treatments the president received for COVID-19 were developed using cells derived from human embryonic tissue. In addition, many of the COVID-19 vaccine candidates were developed using fetal cell lines. Gladstone Senior Investigator Warner Greene explains how valuable fetal tissue research has been to research on cancer, HIV, spinal cord injuries, and many other diseases. He also describes how the president’s 2019 decision to cut federal funding for fetal cell research has damaged that progress.
Gladstone Experts
COVID-19
Virology
Greene Lab
Gladstone in the News
October 18, 2020
abc News—In 2019, the Trump administration suspended federal funding for research involving fetal tissue. Gladstone President Deepak Srivastava explains that if the funding ban had been in place over the last few decades, many important drugs—including treatments for COVID-19—would not have been developed.
Gladstone Experts
COVID-19
Roddenberry Stem Cell Center
Srivastava Lab
Stem Cells/iPSCs
Gladstone in the News
October 17, 2020
Science is Fun!—Director of the Gladstone Institute of Virology Melanie Ott describes her latest work developing a CRISPR-based test for COVID-19, and the prospect for broadly acting antiviral therapeutics.
Gladstone Experts
COVID-19
Virology
Ott Lab
